Table 1.
Characteristic features
| Parameter | n / Mean | % / Median (Range) | |
|---|---|---|---|
| Age (years) | 60.1 | 60 (35–84) | |
| 1988 FIGO Stage | IA | 40 | 18.3 |
| IB | 141 | 64.4 | |
| IC | 16 | 7.3 | |
| IIA | 4 | 1.8 | |
| IIB | 2 | 0.9 | |
| IIIA | 5 | 2.3 | |
| IIIC | 10 | 4.6 | |
| IVB | 1 | 0.5 | |
| 2009 FIGO Stage | IA | 183 | 83.6 |
| IB | 19 | 8.7 | |
| II | 2 | 0.9 | |
| IIIA | 4 | 1.8 | |
| IIIC1 | 5 | 2.3 | |
| IIIC2 | 5 | 2.3 | |
| IVB | 1 | 0.5 | |
| Staging Surgery | Performed | 69 | 31.5 |
| Not performed | 150 | 68.5 | |
| Number of removed pelvic lymph nodes | Pelvic | 39 | 38.5 (10–81) |
| Paraaortic | 10 | 10 (1–24) | |
| Total | 49 | 49 (12–98) | |
| Lymph node metastasis | Negative | 58 | 84 |
| Positive | 11 | 16 | |
| Region of metastatic lymph nodes | Only pelvic region | 5 | 2.3 |
| Only paraaortic region | 2 | 0.9 | |
| Both regions | 4 | 1.8 | |
| Preoperative platelet level (n/mL) | 261.940 | 261.000 (100.000–596.000) | |
| Preoperative haemoglobin level (mg/dL) | 12.3 | 12.7 (4.4–16.1) | |
| Preoperative body mass index (kg/m2) | 34.6 | 34 (18.3–57.3) | |
| Preoperative Ca-125 level (IU/mL) | 55.6 | 9 (2–1834) | |
| Place of probe curettage | Our centre | 99 | 45.2 |
| Other centre | 120 | 54.8 | |
FIGO: International Federation of Gynecology and Obstetrics